Galderma raises 2026 sales guidance. Galderma stock is valued at CHF 45.0 billion

{
  "signal_id": "1ef8f302-3ab1-065d-6db9-4746a510c480",
  "signal_type": "news",
  "signal_subtype": "has_revenue",
  "detected_at": "2026-10-26T09:30:33+00:00",
  "company": {
    "name": "Galderma",
    "domain": "galderma.com"
  },
  "data": {
    "url": "https://www.ad-hoc-news.de/boerse/news/corporate-news/galderma-raises-2026-sales-guidance-galderma-stock-is-valued-at-chf-45-0-billion/70413581",
    "title": "Galderma raises 2026 sales guidance. Galderma stock is valued at CHF 45.0 billion - ad-hoc-news.de",
    "excerpt": "Galderma Group AG (ISIN CH1335392721) raised its 2026 sales growth guidance to 22.5-23.5 percent from 19-21 percent on October 22, 2026, while its stock was valued at CHF 45.0 billion. The higher outlook followed first-nine-month sales of USD 4.765 billion, up 25.1 percent at constant currency, according to Galderma . The October 22 update combined faster growth with a stable profitability target. Galderma confirmed full-year Core EBITDA margin guidance of 26 percent at constant currency while continuing to invest behind its portfolio. Third-quarter sales increased 26.0 percent at constant currency to USD 1.632 billion. The official release said growth was broad based, with Injectable Aesthetics up 13.2 percent, Dermatological Skincare up 16.2 percent and Therapeutic Dermatology up 64.4 percent during the first nine months of 2026. On September 30, 2026, Galderma presented three-year Nemluvio data showing that up to 91 percent of patients achieved at least 75 percent improvement in eczema severity, according to Galderma . On October 14, 2026, it signed an agreement to acquire ZO Skin Health for an enterprise value of USD 1.5 billion, as Galderma announced. The October 22, 2026 trading update then lifted the full-year growth range to 22.5-23.5 percent. Therapeutic Dermatology is the clearest growth engine. First-nine-month sales reached USD 1.347 billion, up 64.4 percent, while...",
    "summary": "Galderma reported third-quarter sales of USD 1.632 billion and first-nine-month sales of USD 4.765 billion.",
    "planning": false,
    "image_url": "https://mdb.ad-hoc-news.de/bild/bild-2405016_1920_1080.webp",
    "confidence": 0.95,
    "published_at": "2026-10-26T09:30:33Z",
    "effective_date": "2026-10-22",
    "article_sentence": "Third-quarter sales increased 26.0 percent at constant currency to USD 1.632 billion.",
    "amount_normalized": 1632000000
  }
}

curl https://signals.autobound.ai/v1/signals/1ef8f302-3ab1-065d-6db9-4746a510c480 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"galderma.com","limit":20}'